News & Articles

Selected Filters:

Antibodies Clear Filters

Editorial Article

How the Bio-Rad Academy is leading the way in ‘advancing science and saving lives’

1 May 2024

Product News

Abzena launches EpiScreen 2.0 immunogenicity platform

1 May 2024

Expert Insights

No antibiotics, ever

22 Apr 2024

Editorial Article

Biopharma techniques to advance new drug modalities

7 Apr 2024

Industry News

Festival of Biologics – San Diego 2024

3 Apr 2024

Product News

Bio-Rad launches validated antibodies for rare cell and CTC enumeration

26 Mar 2024

Industry News

HIV in cell culture can be completely eliminated using CRISPR-Cas gene editing technology

21 Mar 2024

Editorial Article

Proteinase K provides versatility in molecular biology

6 Mar 2024

Product News

Comprehensive autoantibody testing in neurological diseases

5 Mar 2024

Editorial Article

Continuous mRNA manufacturing to boost therapy and vaccine output

28 Feb 2024

News & Articles

Articles Filter

Search

Selected Filters:

How the Bio-Rad Academy is leading the way in ‘advancing science and saving lives’

Abzena launches EpiScreen 2.0 immunogenicity platform

No antibiotics, ever

Biopharma techniques to advance new drug modalities

Festival of Biologics – San Diego 2024

Bio-Rad launches validated antibodies for rare cell and CTC enumeration

HIV in cell culture can be completely eliminated using CRISPR-Cas gene editing technology

Proteinase K provides versatility in molecular biology

Comprehensive autoantibody testing in neurological diseases

Continuous mRNA manufacturing to boost therapy and vaccine output

News & Articles

Articles FilterArticles Filter

Search

Selected Filters:

How the Bio-Rad Academy is leading the way in ‘advancing science and saving lives’

Abzena launches EpiScreen 2.0 immunogenicity platform

No antibiotics, ever

Biopharma techniques to advance new drug modalities

Festival of Biologics – San Diego 2024

Bio-Rad launches validated antibodies for rare cell and CTC enumeration

HIV in cell culture can be completely eliminated using CRISPR-Cas gene editing technology

Proteinase K provides versatility in molecular biology

Comprehensive autoantibody testing in neurological diseases

Continuous mRNA manufacturing to boost therapy and vaccine output

Articles Filter